Orti G, Dachy G, Graham CE, Peric Z, et al. Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practi Bone Marrow Transplant 2025 Apr 9. doi: 10.1038/s41409-025-02567.
PMID: 40205032